SINO BIOPHARMACEUTICAL
Sino Biopharmaceutical engages in pharmaceutical products which covers an array of R&D platforms, a line-up of intelligent production and a strong sales system. The Group's products have gained a competitive foothold in various therapeutic categories with promising potentials, comprising a variety of biopharmaceutical and chemical medicines for treating tumours, liver diseases, cardio-cerebral diseases, analgesia, respiratory system diseases and orthopedicdiseases.
SINO BIOPHARMACEUTICAL
Industry:
Biotechnology Health Care Health Diagnostics Hospital Medical Pharmaceutical
Founded:
1997-02-02
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Nginx Euro Google Apps For Business Pound Sterling Japanese Yen Java EE Network Solutions DNS Unsplash
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Fatigue Science Institute
Fatigue Science is a research, development and sales of medical technology and medical supplies for various diseases, and treatment.
Kanzawa Medical Research Foundation
Kanzawa Medical Research Foundation promotes the development of healthcare and medical science by encouraging studies.
Samjin Pharmaceutical
Samjin Pharmaceutical is a company that pioneeres a healthy life for human beings with a creative mind and advances for a prosperous future.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-03-23 | Softhale | Softhale acquired by Sino Biopharmaceutical | 110 M USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-02 | Generon (Shanghai) Corporation | Sino Biopharmaceutical investment in Venture Round - Generon (Shanghai) Corporation | 70 M USD |
| 2021-12-12 | Medlinker | Sino Biopharmaceutical investment in Series E - Medlinker | 514 M USD |
| 2021-11-18 | Treadwell Therapeutics | Sino Biopharmaceutical investment in Series B - Treadwell Therapeutics | 91 M USD |
| 2021-08-11 | XtalPi | Sino Biopharmaceutical investment in Series D - XtalPi | 400 M USD |
| 2020-12-06 | Sinovac Life Sciences | Sino Biopharmaceutical investment in Corporate Round - Sinovac Life Sciences | 500 M USD |
| 2019-11-04 | Akeso Biopharma | Sino Biopharmaceutical investment in Series D - Akeso Biopharma | 150 M USD |
| 2015-08-05 | LifeBond | Sino Biopharmaceutical investment in Series D - LifeBond | 27 M USD |